Lataa...
Preventive effects of octreotide (SMS 201-995) on diabetic ketogenesis during insulin withdrawal.
1. Exogenous somatostatin inhibits glucagon secretion and prevents ketoacidosis in diabetic patients, but has the therapeutic disadvantage of requiring continuous intravenous infusion to exhibit these effects. 2. Consequently, we examined the effect of subcutaneous administration of the long-acting...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
1991
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1368631/ https://ncbi.nlm.nih.gov/pubmed/1954071 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|